1. Immunomonitoring in glioma immunotherapy: current status and future perspectives

   • Jonathan B. Lamano
   • Leonel Ampie
   • Orin Bloch

   Topic Review 05 December 2015 Pages: 1 - 13

2. Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells

   • Johnathan E. Lawrence
   • Christopher J. Steele
   • Robert J. Winn

   Laboratory Investigation 07 December 2015 Pages: 15 - 21

   

3. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas

   • Shinji Nakashima
   • Yasuo Sugita
   • Motohiro Morioka

   Laboratory Investigation 08 December 2015 Pages: 23 - 32

   

4. Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS)

   • Subhash Chandra
   • Dylan J. Parker
   • Susan C. Pannullo

   Laboratory Investigation 24 December 2015 Pages: 33 - 41

   

5. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients

   • Chunjui Chen
   • Lingchao Chen
   • Hong Chen

   Clinical Study 28 November 2015 Pages: 43 - 52

   

6. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas

   • Trent R. Hummel
   • Ralph Salloum
   • Mariko DeWire

   Clinical Study 01 December 2015 Pages: 53 - 61

   

7. Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial

   • Anthony Pham
   • Menachem Z. Yondorf
   • A. Gabriella Wernicke

   Clinical Study 09 December 2015 Pages: 63 - 71

   

8. One-year outcome of postoperative swallowing impairment in pediatric patients with posterior fossa brain tumor

   • Woo Hyung Lee
   • Byung-Mo Oh
   • Tai Ryoon Han

   Clinical Study 30 November 2015 Pages: 73 - 81

   

9. Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

   • Andrea Horváth
   • Gábor Perlaki
   • Péter Bogner

   Clinical Study 27 November 2015 Pages: 83 - 90

   

10. Primary brain tumor patients’ supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilization

    • Danette Langbecker
    • Patsy Yates

    Clinical Study 07 December 2015 Pages: 91 - 102

    

11. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery

    • Christopher S. Grubb
    • Ashish Jani
    • Tony J. C. Wang

    Clinical Study 28 November 2015 Pages: 103 - 110

    

12. Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome

    • E. Tabouret
    • C. Boucard
    • N. Bruder

    Clinical Study 25 November 2015 Pages: 111 - 117

    

13. Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report

    • Shoji Yomo
    • Motohiro Hayashi

    Clinical Study 30 November 2015 Pages: 119 - 126

    

14. A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas

    • Yazmin Odia
    • Fabio M. Iwamoto
    • Howard A. Fine

    Clinical Study 07 December 2015 Pages: 127 - 135

    

15. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor

    • Mark D. McCurdy
    • Shruti Rane
    • Lisa A. Jacobson

    Clinical Study 02 January 2016 Pages: 137 - 144

16. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors

    • A. Gabriella Wernicke
    • Menachem Z. Yondorf
    • Theodore H. Schwartz

    Clinical Study 02 January 2016 Pages: 145 - 153

    

17. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature

    • Ossama M. Maher
    • Soumen Khatua
    • Wafik Zaky

    Clinical Study 30 December 2015 Pages: 155 - 163

    

18. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide

    • Roy E. Strowd
    • Inas Abuali
    • Stuart A. Grossman

    Clinical Study 04 January 2016 Pages: 165 - 171

    

19. Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation

    • Sylvia Cheng
    • John-Paul Kilday
    • Ute Bartels

    Clinical Study 07 January 2016 Pages: 173 - 180

    

20. The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma

    • Eun Jung Lee
    • Jeong Hoon Kim
    • Chang Jin Kim

    Clinical Study 31 December 2015 Pages: 181 - 190

    

21. Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab

    • Elisabeth Bumes
    • Sarah Rzonsa
    • Peter Hau

    Clinical Study 31 December 2015 Pages: 191 - 200

    

22. Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response

    • Alessia Pellerino
    • Riccardo Soffietti
    • Roberta Rudà

    Letter to the Editor 27 November 2015 Pages: 201 - 203

    

23. Primary Burkitt lymphoma of the fourth ventricle mimicking a medulloblastoma in a child

    • Hao Liu
    • Haiman Hou
    • Jingliang Cheng

    Letter to the Editor 24 December 2015 Pages: 205 - 207